Showing results (41-50 of 52) with videos related to
Sort By:
Pageof 6
Human Immunology|September 1, 1989
Loss of tolerance associated with disappearance of B cells in a patient sequentially transplanted with paternal and maternal bone marrow for the treatment of severe combined immunodeficiency diseaseC A Keever, N Flomenberg, T Small, et al.Blood|June 1, 1990
Anti-leukemia potential of interleukin-2 activated natural killer cells after bone marrow transplantation for chronic myelogenous leukemiaM Hauch, M V Gazzola, T Small, et al.Blood|July 9, 1999
T-cell depletion plus salvage immunotherapy with donor leukocyte infusions as a strategy to treat chronic-phase chronic myelogenous leukemia patients undergoing HLA-identical sibling marrow transplantationW R Drobyski, M J Hessner, J P Klein, et al.Human Immunology|September 1, 1990
Cytotoxic and proliferative T-cell clones with antidonor reactivity from a patient transplanted for severe combined immunodeficiency diseaseC A Keever, N Flomenberg, M V Gazzola, et al.Blood|November 15, 1995
Use of unrelated marrow grafts compensates for reduced graft-versus-leukemia reactivity after T-cell-depleted allogeneic marrow transplantation for chronic myelogenous leukemiaM J Hessner, D J Endean, J T Casper, et al.Blood|April 1, 1989
Immune reconstitution following bone marrow transplantation: comparison of recipients of T-cell depleted marrow with recipients of conventional marrow graftsC A Keever, T N Small, N Flomenberg, et al.Bone Marrow Transplantation|November 8, 2005
Alternative donor bone marrow transplant for children with Philadelphia chromosome ALLJ M Talano, J T Casper, B M Camitta, et al.Bone Marrow Transplantation|July 1, 1994
HLA-B44-directed cytotoxic T cells associated with acute graft-versus-host disease following unrelated bone marrow transplantationC A Keever, N Leong, I Cunningham, et al.Blood|October 15, 1993
Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell doseW R Drobyski, C A Keever, M S Roth, et al.Bone Marrow Transplantation|June 1, 1997
Effect of T cell subset dose on outcome of T cell-depleted bone marrow transplantationY Kawanishi, J Passweg, W R Drobyski, et al.Pageof 6